2025 ahead ayondo Franchise coming soon
Happy 
xMas Holidays
xMas Holidays
xMas Holidays
|
DGAP-News: STRATEC SE
/ Key word(s): Personnel
STRATEC SE: DR. RUDOLF EUGSTER AS NEW CHAIR OF SUPERVISORY BOARD / PLANNED INCREASE IN NUMBER OF SUPERVISORY BOARD MEMBERS Birkenfeld, November 3, 2021 STRATEC SE, Birkenfeld, Germany, (Frankfurt: SBS; Prime Standard, SDAX) can today announce that Dr. Rudolf Eugster has been appointed by Mannheim District Court to be a member of the Supervisory Board of STRATEC SE as of October 26, 2021. Furthermore, at its meeting today the Supervisory Board elected Dr. Rudolf Eugster as the new Chair of the Supervisory Board. Given the various management positions he has held in companies with international operations, Dr. Rudolf Eugster has longstanding experience in strategic planning and in financial reporting and controlling. Among other roles, he was a member of the Board of Management at Tecan Group AG (SIX Swiss Exchange: TECN) from 2002 to 2020 and has in-depth knowledge of the STRATEC Group's target markets. Dr. Rudolf Eugster is a Swiss citizen and holds a degree in chemistry, a doctorate in technical sciences, and a postgraduate qualification in business administration, all of which obtained at the Swiss Federal Institute of Technology in Zurich (ETH Zürich), Switzerland. The court appointed the new Supervisory Board member in response to a petition submitted by the Board of Management of STRATEC SE. This was necessitated by Prof. Dr. Stefanie Remmele standing down from her positions as a member and as the Chair of the Supervisory Board of STRATEC SE as of October 22, 2021 due to personal reasons. Dr. Frank Hiller, Deputy Chair of the Supervisory Board of STRATEC SE: "We are delighted to have gained an extremely experienced manager in Dr. Rudolf Eugster, one who can look back on more than 20 years of activity as CFO. The company's management would also like to thank Prof. Dr. Stefanie Remmele for her constructive and competent work and for the contribution she made to the company's success over the past seven years, of which around one year as Chair of the Supervisory Board." To account for external requirements and its own targets in terms of diversity, as well as to further widen the range of experience available on the board, the company also plans to request approval from the next Annual General Meeting for an increase in the number of Supervisory Board members from its present total of three to five. ABOUT STRATEC The partners market the systems, software, and consumables, in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world. STRATEC develops its products on the basis of its own patented technologies. Shares in the company (ISIN: DE000STRA555) are traded in the Prime Standard segment of the Frankfurt Stock Exchange and are listed in the SDAX select index of the German Stock Exchange. FURTHER INFORMATION IS AVAILABLE FROM:
03.11.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
| Language: | English |
| Company: | STRATEC SE |
| Gewerbestr. 37 | |
| 75217 Birkenfeld | |
| Germany | |
| Phone: | +49 (0)7082 7916 0 |
| Fax: | +49 (0)7082 7916 999 |
| E-mail: | info@stratec.com |
| Internet: | www.stratec.com |
| ISIN: | DE000STRA555 |
| WKN: | STRA55 |
| Indices: | SDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1245561 |
| End of News | DGAP News Service |
|
|
1245561 03.11.2021
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.
